Abbott Net Income Applicable To Common Shares from 2010 to 2026
| ABL Stock | EUR 93.71 1.96 2.05% |
Net Income Applicable To Common Shares | First Reported 2016-12-31 | Previous Quarter 1.4 B | Current Value 1.4 B | Quarterly Volatility 705.4 M |
Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Discontinued Operations of 20.5 M, Interest Expense of 414.6 M or Selling General Administrative of 10.3 B, as well as many indicators such as . Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
Abbott | Net Income Applicable To Common Shares |
The Net Income Applicable To Common Shares trend for Abbott Laboratories offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Abbott Laboratories is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Abbott Laboratories' Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Abbott Laboratories over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Abbott Laboratories' Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abbott Laboratories' overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Abbott Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 3,991,126,471 | |
| Geometric Mean | 3,248,123,408 | |
| Coefficient Of Variation | 58.59 | |
| Mean Deviation | 1,961,780,969 | |
| Median | 3,666,000,000 | |
| Standard Deviation | 2,338,460,446 | |
| Sample Variance | 5468397.3T | |
| Range | 7.5B | |
| R-Value | 0.74 | |
| Mean Square Error | 2607956.3T | |
| R-Squared | 0.55 | |
| Significance | 0.0006 | |
| Slope | 344,334,436 | |
| Total Sum of Squares | 87494356.2T |
Abbott Net Income Applicable To Common Shares History
About Abbott Laboratories Financial Statements
Abbott Laboratories stakeholders use historical fundamental indicators, such as Abbott Laboratories' Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in Abbott Laboratories' assets and liabilities are reflected in the revenues and expenses on Abbott Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Abbott Laboratories. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 7.9 B | 4 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Abbott Laboratories Correlation against competitors. For more detail on how to invest in Abbott Stock please use our How to Invest in Abbott Laboratories guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.